scholarly journals An Emergency Department Management on Acute Asthma Exacerbations in Children Younger than 12 Years

2021 ◽  
pp. 68-71
Author(s):  
Waqas Latif ◽  
Rehan Zahoor ◽  
Maiera Khalid
Keyword(s):  
Emergency Department ◽  
Medical Practice ◽  
Clinical Audit ◽  
Acute Asthma ◽  
Asthma Management ◽  
Age And Gender ◽  
Asthma Exacerbations ◽  
Emergency Department Management ◽  
And Gender ◽  
Acute Asthma Exacerbations

Objectives: The main objective of the study is to clinically audit and analyse the acute asthma exacerbations in children younger than 12 years regarding management of emergency department. Methods: This clinical audit was done in Bahawal Victoria Hospital, Bahawalpur during January 2020 till June 2020. We retrospectively revised all the files of children aged 0–12 years who were visited for acute asthma in the Paediatric ED of Hospital. All the patients with a diagnosis of “acute asthma,” “wheezing bronchitis,” and “bronchospasm” were included. Results: A total of 864 patients were seen in the Emergency Department during the study. Of these, a total of 293 patients were seen for a presentation of acute asthma. As some patients had multiple visits, the 293 records represented 278 unique patients. For assessing age and gender distribution of the patients, only data from the first visit were used. Otherwise, each record was treated independently for the purpose of analyses. Conclusion: It is concluded that acute asthma management still remains an area of medical practice that continues to have long-standing difficulties.

Pediatric acute asthma exacerbations: Evaluation and management from emergency department to intensive care unit

2016 ◽  
Vol 53 (6) ◽  
pp. 607-617 ◽  
Author(s):  
Brittany Pardue Jones ◽  
Geoffrey M. Fleming ◽  
Jaime Kaye Otillio ◽  
Ishan Asokan ◽  
Donald H. Arnold
Keyword(s):  
Intensive Care Unit ◽  
Emergency Department ◽  
Intensive Care ◽  
Acute Asthma ◽  
Asthma Exacerbations ◽  
Acute Asthma Exacerbations

scholarly journals A Randomized clinical Trial of Inhaled Ciclesonide for Acute Asthma.

2020 ◽  
Author(s):  
Demétrius Tierno Martins ◽  
Karla Carlos ◽  
Luciane BC Carvalho ◽  
Lucila Bizari Prado ◽  
Carolina Fransolin ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Emergency Department ◽  
Placebo Group ◽  
Randomized Clinical Trial ◽  
Acute Asthma ◽  
Respiratory Effort ◽  
Double Blind ◽  
Asthma Exacerbations ◽  
Systemic Corticosteroids ◽  
Acute Asthma Exacerbations

Abstract Background: Current guidelines for management of acute asthma exacerbations advocate the administration of short-acting bronchodilators and systemic corticosteroids. The use of inhaled corticosteroids for this purpose has been tested since the 1990s, but the optimal agent, dose, and strategy have yet to be defined. Within the context, we designed a double-blind, randomized clinical trial aiming to compare high doses of inhaled ciclesonide to systemic corticosteroids in the treatment of acute asthma exacerbations in the emergency department. Methods: This double-blind, randomized clinical trial enrolled 58 patients with a clinical diagnosis of bronchial moderate and severe asthma by GINA(Global Initiative for Asthma) criteria who presented to the emergency department with peak flow <50% of predicted. Patients were randomized into two groups. Over the course of 4 hours, one group received 1440 mcg inhaled ciclesonide plus hydrocortisone-identical placebo (ciclesonide + placebo group), while the other received 500 mg intravenous hydrocortisone plus ciclesonide-identical placebo (hydrocortisone + placebo group). Both groups received short-acting bronchodilators (fenoterol hydrobromide and ipratropium bromide) as recommended by GINA. The research protocol included spirometry, rigorous and frequent clinical evaluation (dyspnea, accessory muscle use, wheezing, respiratory effort), and vital signs and ECG monitoring. Data were obtained at baseline, 30, 60, 90, 120, 180, and 240 minutes. We compared data from baseline to hour 4 between and within groups. Results: Overall, 31 patients received ciclesonide + placebo and 27 received hydrocortisone + placebo. Inhaled ciclesonide was as effective as intravenous hydrocortisone in improving clinical parameters (Borg-scored dyspnea, p=0.95; sternocleidomastoid muscle use, p=0.55; wheezing, p=0.55; respiratory effort, p=0.95) and spirometric parameters (forced vital capacity, p=0.50; forced expiratory volume in the first second, p=0.83; peak expiratory flow, p=0.51).Conclusions: Inhaled ciclesonide was non-inferior to systemic hydrocortisone for management of acute asthma exacerbations, improving both clinical and spirometric parameters.Trial registration: RBR-6XWC26 - Registro Brasileiro de Ensaios Clínicos (http://www.ensaiosclinicos.gov.br/rg/RBR-6xwc26/). Date of registration: 05/01/2016 'retrospectively registered'.

scholarly journals Pregnancy related treatment disparities of acute asthma exacerbations in the emergency department

2011 ◽  
Vol 105 (10) ◽  
pp. 1434-1440 ◽  
Author(s):  
Jennifer W. McCallister ◽  
Cathy G. Benninger ◽  
Heather A. Frey ◽  
Gary S. Phillips ◽  
John G. Mastronarde
Keyword(s):  
Emergency Department ◽  
Acute Asthma ◽  
Asthma Exacerbations ◽  
Treatment Disparities ◽  
Acute Asthma Exacerbations
Sign in / Sign up

Export Citation Format

Share Document